Zhejiang Wecome Pharmaceutical (300878.SZ) and its controlling shareholder Liu Zhongliang have been investigated by the China Securities Regulatory Commission for suspected violations of laws and regulations related to disclosure of information.

Zhejiang Wecome Pharmaceutical (300878.SZ) issued an announcement that the company and its actual controller, Liu Zhongliang, received a "Notice of Case Filing" (No. 01120240040, No. 01120240041) from the China Securities Regulatory Commission on December 27, 2024. They are suspected of illegal disclosure of information. According to the laws and regulations such as the Securities Law of the People's Republic of China and the Administrative Penalty Law of the People's Republic of China, the China Securities Regulatory Commission has decided to file a case against the company and its actual controller, Liu Zhongliang.